Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

TetraLogic Slashes Two-Thirds of Workforce After Mid-Stage Trial Failure

January 22, 2016By Alex Keown, Breaking News Staff   PHILADELPHIA – TetraLogic Pharmaceuticals (TLOG) plans to eliminate two-thirds of its employees by next month following the failure of a Phase II treatment for high-risk patients with myelodysplastic syndromes earlier this month. The company filed a regulatory report with the U.S. Securities and Exchange Commission […]

Read More »

U.S. government suspends enrollment in Cigna Medicare Advantage, drug plans

The U.S. government has suspended new enrollment in Cigna Corp’s Medicare Advantage health plans for seniors and standalone Medicare prescription drug plans, citing noncompliance in its appeals and grievances procedures. The government said Cigna had deficiencies in its appeals and grievances processes in both Medicare Advantage and the Medicare prescription drug program, according to a […]

Read More »

Johnson & Johnson Halts Trial of Drug Similar to One Linked to Brain Dead Tragedy in France

NEW BRUNSWICK, N.J. — Johnson & Johnson (JNJ) has halted a trial of an experimental fatty acid amide hydrolase inhibitor, a drug similar to one being tested in France by a Portuguese pharmaceutical company that left one patient brain dead and five others hospitalized, Reuters reported this morning. A Johnson & Johnson spokesperson told Reuters […]

Read More »

GlaxoSmithKline (GSK) Kills U.S. Part of Eczema Treatment Deal With Basilea (BSLN.SW)

GlaxoSmithKline (GSK), headquartered in Basel, Switzerland, announced yesterday that it had ended its deal with Swiss company Basilea Pharmaceutica Ltd. (BSLN.SW) to develop alitretinoin in the U.S. In June 2012, the two companies, both headquartered in Basel, Switzerland, entered into an exclusive global agreement for Toctina. The drug was at that time being marketed in […]

Read More »

FDA gives full approval to Amgen blood cancer drug

The U.S. Food and Drug Administration said on Thursday it has approved Amgen Inc’s cancer drug Kyprolis in combination with certain other therapies to treat patients with multiple myeloma. The agency also approved the drug as a single agent for patients with relapsed or refractory multiple myeloma who have received one or more previous treatments. […]

Read More »

Nephron Pharma Cuts Another 250 Employees At Orlando HQ

January 21, 2016By Alex Keown, Breaking News Staff   ORLANDO – Florida-based Nephron Pharmaceuticals is slashing another 250 jobs at its Orlando manufacturing facility, the Orlando Business Journal reported Thursday afternoon. The maker of generic respiratory medications filed a WARN notice with the Florida Department of Economic Opportunity saying that 250 workers will be […]

Read More »

What to expect when you’re expecting two feet of snow

With a huge winter storm looming over the eastern United States, many of the region’s residents will stock up on canned goods, bottled water and – for some – diapers. The storm, which is expected to pound the Mid-Atlantic states on Friday and Saturday, has mothers-to-be asking a simple, yet vital, question: What do you […]

Read More »

Aetna’s deal for Humana will push up costs for seniors: think tank

Aetna Inc’s (AET.N) plan to buy smaller insurer Humana Inc (HUM.N) for $31 billion will mean seniors will pay higher Medicare Advantage premiums, according to a new report by the think tank Center for American Progress (CAP). Aetna’s proposed deal for Humana would combine Aetna’s 7 percent of the Medicare Advantage market with Humana’s 19 […]

Read More »

Novo aims to be ahead of pharma pack with Iran investment

Danish drugmaker Novo Nordisk, the world’s top insulin supplier, expects to be ahead of the pack now nuclear sanctions are lifted in Iran, thanks to a continuous presence and a pre-emptive investment plan.   The country is an attractive target for Big Pharma seeking to sell new medicines to its large and growing population, but […]

Read More »

Drug firms ask governments to do more in fight against superbugs

More than 80 international drug and biotech firms urged governments to work with them to combat drug-resistant superbugs which could kill tens of millions of people within decades unless progress is made and new antibiotics found.   In a declaration at the World Economic Forum in Davos, they called for coordinated efforts to cut unnecessary […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom